Section 721.10829 - Xanthylium, x-[2-(alcoxycarbonyl)phenyl] -bis(alkylamino)-dimethyl-, x'-[x" -[hydroxy-x"'-[[[[hydroxy-x''''-(phenyldiazenyl)-sulfo-2-naphthalenyl] amino]carbonyl]amino]sulfo- naphthalenyl]diazenyl]benzoate, sodium salt (generic)(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substance identified generically as xanthylium, x-[2-(alcoxycarbonyl)phenyl]-bis(alkylamino)-dimethyl-, x'-[x" -[hydroxy-x"'-[[[[hydroxy-x''''-(phenyldiazenyl)-sulfo-2-naphthalenyl] amino]carbonyl]amino]sulfo- naphthalenyl]diazenyl]benzoate, sodium salt (PMN P-14-800) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.(2) The significant new uses are: (i)Release to water. Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 1).(ii) [Reserved](b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1)Recordkeeping. Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers and processors of this substance.(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.